Vimta Labs Ltd. — Investor Relations & Filings
Vimta Labs Ltd. is a contract research and testing organization providing comprehensive scientific services across multiple sectors. The company specializes in analytical testing, clinical research, preclinical studies, and environmental monitoring. Its service portfolio includes pharmaceutical analysis, biopharmaceutical characterization, food safety testing, and diagnostic services. Vimta operates advanced laboratory facilities equipped to handle complex regulatory requirements, including compliance with global standards such as GLP, GCP, and ISO. The organization supports the life sciences, food, and electronics industries by offering specialized services like molecular biology, microbiology, and toxicology assessments. By integrating multi-disciplinary expertise, the company facilitates product development, quality control, and safety evaluations for a global clientele.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Investor Call Transcript- FY 2025-26- Q4 Earnings/ Investor Call held on 06th May 2026 | 2026-05-12 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-12 | English | |
| Copy of Newspaper Publication | 2026-05-07 | English | |
| Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-06 | English | |
| Change in Director(s) | 2026-05-06 | English | |
| Record Date | 2026-05-06 | English |
Browse filings by year
17 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 45272164 | Investor Call Transcript- FY 2025-26- Q4 Earnings/ Investor Call held on 06th May 2026 | 2026-05-12 | English | ||
| 45261702 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-12 | English | ||
| 42965355 | Copy of Newspaper Publication | 2026-05-07 | English | ||
| 42163555 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-05-06 | English | ||
| 42166181 | Change in Director(s) | 2026-05-06 | English | ||
| 42171177 | Record Date | 2026-05-06 | English | ||
| 42171303 | Outcome of Board Meeting | 2026-05-06 | English | ||
| 42171271 | Dividend | 2026-05-06 | English | ||
| 42172778 | Press Release | 2026-05-06 | English | ||
| 42173852 | Investor Presentation | 2026-05-06 | English | ||
| 42174392 | Outcome of Board Meeting | 2026-05-06 | English | ||
| 42186784 | Analysts/Institutional Investor Meet/Con. Call Updates | 2026-04-29 | English | ||
| 42275161 | Board Meeting — Financial Results/Dividend | 2026-04-29 | English | ||
| 42275145 | Board Meeting — Board Meeting Intimation | 2026-04-29 | English | ||
| 42200408 | Copy of Newspaper Publication | 2026-04-28 | English | ||
Market data
Market data not available
Price history
Peer group · Research and experimental development on natural sciences and engineering
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Poxel
Biopharma developing treatments for metabolic diseases, wit…
|
POXEL | FR | Professional, scientific and te… |
|
PPK GROUP LIMITED
Commercializes innovative nanomaterials and advanced energy…
|
PPK | AU | Professional, scientific and te… |
|
PRECISION BIOSCIENCES INC
Clinical-stage gene editing company developing therapies fo…
|
DTIL | US | Professional, scientific and te… |
|
Predictive Oncology Inc.
Applies AI and a biobank to predict drug response for oncol…
|
POAI | US | Professional, scientific and te… |
|
Predict S.p.A.
Develops and distributes AI medical solutions for imaging, …
|
PRE | IT | Professional, scientific and te… |
|
PRESCIENT THERAPEUTICS LIMITED
Clinical-stage oncology firm developing modular cell therap…
|
PTX | AU | Professional, scientific and te… |
|
PreveCeutical Medical
Health sciences company researching and developing innovati…
|
PREV | CA | Professional, scientific and te… |
|
ProMIS Neurosciences Inc.
Develops selective antibody therapeutics for neurodegenerat…
|
PMN | CA | Professional, scientific and te… |
|
Propanc Biopharma, Inc.
Clinical-stage company developing cancer treatments to prev…
|
PPCB | US | Professional, scientific and te… |
|
ProQR Therapeutics N.V.
Develops RNA therapies for severe genetic disorders using i…
|
PRQR | NL | Professional, scientific and te… |
Vimta Labs Ltd. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/61730/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=61730 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=61730 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=61730 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 61730}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Vimta Labs Ltd. (id: 61730)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.